Sort
34,240 grants matching “atherosclerosis”
Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence
$1,009,228Piotr J Slomka · Cedars-Sinai Medical Center · R35 · FY2023 · HL
Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence
$1,009,179Piotr J Slomka · Cedars-Sinai Medical Center · R35 · FY2025 · HL
Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS
$1,008,629Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2025 · HL
Family Study of Stroke Risk and Carotid Atherosclerosis
$1,008,355Columbia University Health Sciences · R01 · FY2003 · NS
Genetic Susceptibility To Carcinogens
$1,008,257Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Protective Mechanisms In Cerebral Ischemia
$1,007,933John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Improved long-term biocompatibility of coronary stents by plasma coating process
$1,007,682Meng Chen · Nanova, Inc. · R44 · FY2019 · HL
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
$1,007,638Pamela Lutsey · University Of Minnesota · N01 · FY2024 · HL
SCOR IN MOLECULAR MEDICINE AND ATHEROSCLEROSIS
$1,007,540Beth Israel Deaconess Medical Center · P50 · FY2001 · HL
Fibrotic Sequelae of Childhood Renal Disease
$1,007,507Agnes B Fogo · Vanderbilt University · P50 · FY2006 · DK
Endothelial Dysfunction, Oxidative Stress and Risk of Peripheral Arterial Disease
$1,006,905Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Artherosclerosis/bone loss/drug use/HIV in older men
$1,006,713Montefiore Medical Center (Bronx, Ny) · R01 · FY2004 · DA
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study
$1,006,655James S Floyd · University Of Washington · R01 · FY2018 · HL
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$1,004,250Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2008 · HL
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$1,004,250Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2009 · HL
Chronic Kidney Disease in Children (CKiD)
$1,004,040Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2009 · DK
Novel vascular smooth muscle cell progenitors in development and disease
$1,003,982Daniel Greif · Yale University · R35 · FY2022 · HL
Novel vascular smooth muscle cell progenitors in development and disease
$1,003,982Daniel Greif · Yale University · R35 · FY2023 · HL
Novel vascular smooth muscle cell progenitors in development and disease
$1,003,982Daniel Greif · Yale University · R35 · FY2025 · HL
Novel vascular smooth muscle cell progenitors in development and disease
$1,003,982Daniel Greif · Yale University · R35 · FY2021 · HL
Novel vascular smooth muscle cell progenitors in development and disease
$1,003,144Daniel Greif · Yale University · R35 · FY2020 · HL
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)
$1,002,814University Of Texas Hlth Sci Ctr San Ant · U01 · FY2003 · DK
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
$1,002,379Loren D Erickson · University Of Virginia · R01 · FY2025 · AI
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,002,374Karin E. Bornfeldt · University Of Washington · R35 · FY2024 · HL
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
$1,001,222Sudha Seshadri · Boston University Medical Campus · UH2 · FY2017 · NS